Press Coverage

HIV medication – numerous patent lawyers lend their support in dispute concerning Truvada (Juve)

Seven manufacturers of pharmaceuticals may for the time being continue marketing their generic products based on the HIV drug Truvada in Germany. The Regional Court of Munich rejected the applications of the US pharma concern Gilead for interim injunctions against Aliud, Betapharm, Hexal, Hormosan, Mylan dura, TAD and Zentiva.

Representatives from Maiwald: Dr Dirk BühlerHeike Röder-HitschkeDr Derk Vos, and Dr Annelie Wünsche

The complete JUVE article can be downloaded under: http://www.juve.de/nachrichten/verfahren/2017/09/hiv-medikament-zahlreiche-patentrechtler-flankieren-patentstreit-um-truvada

 

 

 

Newsletter